Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure
This is a multi-centre, phase II, open-label, 12-month clinical trial for patients previously
treated with WST09 (Tookad) who have positive prostate biopsies for cancer.
The study aims at delivering a second WST09 treatment for the purpose of eradicating the
localized prostate cancer.
Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
Phase 2/Phase 3
The aim of this clinical trial is to evaluate the efficacy and safety of the WST09-mediated
vascular-targeted photodynamic therapy (VTP) in patients with localized prostate cancer
recurrent after external radiation therapy or temporary (High Dose Rate, or HDR)
Study of WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
The aim of this clinical study is to determine the optimal treatment conditions to achieve
prostate cancer tumor ablation and to assess the effects of WST11 mediated VTP treatment in
patients with localized prostate cancer.
The secondary objectives is to evaluate safety and quality of life ; to assess the
pharmacokinetic parameters and to model the relationship between concentration and effects;
and to assess the effects, the safety and quality of life of a second WST11 VTP treatment in
patients with persistent or recurrent localized prostate cancer after a first VTP;
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.